PATENT CLAIM ANALYSIS

Application Number: 16204398
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "203100"]

Abstract:
In various aspects, the invention relates to immune tolerant glycosidase therapy. The invention provides methods for treating or preventing infectious disease, including chronic viral infections, and highly contagious infectious agents that present an ongoing challenge for the immune system. The compositions and treatment regimens find use with other antiviral or antimicrobial therapies, as well as in conjunction with vaccination to boost effectiveness and/or extend the duration of protective effect. In certain embodiments, the regimen described herein reduces or eliminates the need for administration of other traditional antiviral or antimicrobial therapies. In various embodiments, the invention finds use in immunocompromised patients to boost immune function.

Claim (Index 20):
The method of  claim 19 , wherein the bacteria is  Mycobacterium tuberculosis.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.57534
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14569501', '14462285', '14321413', '13080109', '14182296']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.738694037802369
- 35 USC 102 Novelty (BERT): 0.514238879845969
- Combined Prediction Score: 0.716248522006729
- Mean Citation Score: 238.323452
- Max Citation Score: 258.02826
- Similarity Product: 155.77613144808768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test